The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 Presidents Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 Presidents Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Trial Academy Master Class 6.0
    • The Business Of Law
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Hip & Knee Implant Replacement Failure: New Is Not Always Improved

Posted on March 11, 2013 by Andrew Findley


Lawyersandsettlements.com; March 10, 2013

Toronto, ON: Loren Kransky knows all too well that bigger is not always better, and new is not necessarily Nirvana. After suffering from an allegedly defective DePuy hip, the retired prison guard this week was awarded $8.3 million by a California jury in Kransky’s hip replacement lawsuit.

If there is anything akin to a perfect storm in the medical field, it is the combination of an aging (and sizable) segment of the population, the need and desire for artificial hips and knees to prolong an active lifestyle, and the current practice of the US Food and Drug Administration (FDA) to allow for a pass from intensive testing provided a new medical device is similar to those already on the market. The result can be hip and knee replacement implant failure on a grand scale.

But there is nothing grand about it, as noted Canadian writer and columnist Margaret Wente observes in The Globe & Mail (3/1/13), Canada’s venerable national newspaper. Writing in the first-person, Wente revisits her own journey to regain her mobility with the aid of artificial hips.

Several years ago, in her early 50s, Wente required hip implants. Based on her extensive research at the time, the new age metal-on-metal products manufactured by DePuy Orthopaedics showed much promise, and she underwent hip replacement surgery for both hips, on two separate occasions, to receive the all-metal system.

Wente is quick to point out that unlike others who have experienced problems, and as a result, have filed a hip replacement lawsuit, she is fine. There have been no problems so far.

The writer acknowledges, however, that others have not been as lucky.

Wente tells the story of hip & knee replacement implant failure victim Gloria McSherry, who received a Zimmer Durom Cup hip replacement in 2007. Wente describes the outcome as “a catastrophe” for McSherry, who was once an avid runner. “I just could not get well. I got these incredible episodes of pain where I felt as if it would exit my body,” McSherry is quoted as telling Wente.

McSherry eventually underwent revision surgery and had the problematic hip replacement removed and replaced with one featuring a more traditional design, about three years later.

Wente makes the point that an acceptable failure rate for medical devices is commonly held at about one percent. Compare that with reported failure rates of between 35 and 40 percent in Australia and the UK, and reported failure rates of nearly 40 percent in the US for the DePuy hip replacement system (the manufacturer, according to Wente, claims a failure rate of about 12 or 13 percent). Little wonder that so many hip and knee replacement patients have filed a hip replacement lawsuit.

As have knee implant patients, who have found problems with newly designed artificial knees designed to require less-invasive surgery, and to last longer than more traditional implants. Rather than increased mobility, thanks to these much-lauded marvels of modern engineering, patients are left to fight a knee replacement lawsuit.

The lawsuits are compelling. Johnson & Johnson (J&J), the largest drug and medical device manufacturer in the world with global sales of $65 billion and reported profits of $9.7 billion in 2011, holds DePuy Orthopaedics under its wing. J&J is currently facing in excess of 10,000 hip replacement lawsuits with legal documents, according to Wente, running to 50 million pages.

The first DePuy trial that just ended with a finding for plaintiff Kransky in California has been watched closely. According to the Los Angeles Times (3/8/13), Kransky was awarded $338,136 for his medical bills and $8 for pain and suffering. J&J has signaled it will appeal the jury verdict, even in the face of a “win” of its own – while the jury found Kransky’s DePuy hip to be defective, jurors did not agree that J&J failed to warn doctors about defective DePuy hips and thus did not award punitive damages. Wente, meanwhile, reports that insiders speculate that J&J is in the throes of negotiating (or attempting to negotiate) settlements in 10,750 cases that may cost the pharmaceutical and medical device juggernaut $2 billion, “a sum that will barely dent its profits,” Went writes.

And while some problematic all-metal hip and knee implants have been recalled, and surgeons are using them less frequently amidst all the controversy, Wente reports that some surgeons are still, indeed, favoring the all-metal design in spite of high failure rates and concerns over metallosis, a condition that results in minute metal particles wearing off the device and either becoming imbedded in tissue or entering the bloodstream.

Wente herself received the DePuy hip resurfacing system, which was never approved in the US but was approved in Canada and other countries.

As for Gloria McSherry, who is participating in a hip replacement lawsuit, she told Wente: “My life will never be the same,” she says. “I never dreamed that I could ever have anything like that happen to me.”

http://www.lawyersandsettlements.com/articles/hip_and_knee_replacement_implant_failure/hip-knee-replacement-implant-failure-20-18543.html?utm_expid=3607522-0&utm_referrer=http%3A%2F%2Fwww.lawyersandsettlements.com%2F#.UT3s6_XRZfw

Posted in Blog, Newsletter

Comments are closed.

Recent Posts

No thumbnail available

Things to Consider When You Sue an Insurance Provider

May 24th, 2022

We are all too acquainted with insurance coverage in our everyday lives. According to Investopedia, everyone should have[Read More...]
The Rochester Diocese Offers a $147 Million Settlement to Sex Abuse Survivors

The Rochester Diocese Offers a $147 Million Settlement to Sex Abuse Survivors

May 23rd, 2022

The Rochester Catholic Diocese is offering a $147 million settlement to sex abuse survivors. This offer comes as a federal ba[Read More...]
Jury Awards $77.5 Million to an Army Veteran in a 3M Earplug Case

Jury Awards $77.5 Million to an Army Veteran in a 3M Earplug Case

May 23rd, 2022

A jury in Pensacola, Fla., federal court on Friday ordered 3M to pay $77.5 million to a U.S. Army veteran who said he suffe[Read More...]
The New Mexico Supreme Court Upholds $165 Million Damage Awards in a Deadly FedEx Crash

The New Mexico Supreme Court Upholds $165 Million Damage Awards in a Deadly FedEx Crash

May 20th, 2022

The New Mexico Supreme Court on Thursday upheld $165 million of jury awards against FedEx in a wrongful-death lawsuit stemmin[Read More...]
Noom Reaches a $56 Million Class Action Settlement Over Its Autorenewal and Cancellation Policy

Noom Reaches a $56 Million Class Action Settlement Over Its Autorenewal and Cancellation Policy

May 20th, 2022

Weight-loss program Noom has agreed to a $56 million settlement to resolve class action claims regarding its autorenewal and [Read More...]

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.